Patrick Timmins

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.

Anna S. Kadish, Patrick Timmins, Yuexian Wang et al. · PubMed · 2002 · 132 citations

Cervical Intraepithelial Neoplasia, Immunology, Pathology +20

Vaginal evisceration: presentation and management in postmenopausal women.

Lindsey Kowalski, Jan C. Seski, Patrick Timmins et al. · PubMed · 1996 · 113 citations

GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment

Beth L. Worley, Yeon Kim, Jennifer Mardini et al. · Redox Biology · 2018 · 65 citations · Full text